Taseko Mines highlights positive achievements and progress towards copper production
Taseko Mines Limited (NYSE:TGB) is a cheap penny stock to consider. Their annual Sustainability Report, C2 (Copper x Community), emphasizes
Author: MarketNewsData
Your go-to source for real-time financial news and market analysis. Powered by AI. Covering earnings, economic events, and corporate news.
Vertiv introduces energy-efficient cooling and power system for NVIDIA GB300 NVL72 Platform
Vertiv Holdings Co. (NYSE:VRT) releases a 142kW cooling and power reference architecture for the NVIDIA GB300 NVL72 platform, offering integrated
Progressive launches initiative to support first-generation homebuyers with education and grants
Progressive Corporation announced the “Open the House” initiative to promote homeownership education and affordability for first-generation homebuyers. The UpPayment program
Robinhood (HOOD) — is it too late to buy?
🔼 No—But Entry Now Requires Caution and a Strategy. ✅ Why It Still Looks Bullish (Medium Term) ⚠️ Short-Term Risks
SoundHound AI experienced revenue growth and deals signed, but faces competition risk
In recent quarters, a company has seen revenue growth accelerate, with the latest period showing a more than 150% increase.
Possible Social Security benefit cuts by 2033 due to funding shortfall, with bipartisan cooperation needed.
The Social Security Board of Trustees Report has been forecasting a funding shortfall every year since 1985, with potential changes
FDA grants priority review to Merck's WINREVAIR for treating pulmonary arterial hypertension, positive.
Merck & Co., Inc. (NYSE:MRK) announced FDA acceptance and priority review for its supplemental Biologics License Application for WINREVAIR, previously
FDA approved Thermo Fisher Scientific's Oncomine Dx Express Test for lung cancer mutations.
Thermo Fisher Scientific Inc. (NYSE:TMO) received FDA approval for its Oncomine Dx Express Test on the Ion Torrent Genexus Dx
Motorola Solutions introduced a new mini PC with advanced features and security measures.
Motorola Solutions, Inc. (NYSE:MSI) introduced the new mini PC Cubi NUC AI+ 2MG on June 19. This compact device features
Alcon Inc. receives approval for innovative intraocular lens, achieving high light utilization
Alcon Inc. (NYSE: ALC) announces approval of Clareon PanOptix Pro intraocular lens, with proprietary ENLIGHTEN NXT Optical technology achieving 94%
Barclays maintains Hold rating on ONEOK after missing EPS estimates, but sees growth in volumes
ONEOK, Inc. (NYSE:OKE) is listed among the 11 Best 52-Week Low Stocks to Buy Right Now. Barclays analyst Theresa Chen
Merck & Co gets approval for ENFLONSIA vaccine to prevent respiratory syncytial virus in infants
Merck & Co., Inc. (NYSE:MRK) receives approval for ENFLONSIA to prevent respiratory syncytial virus in infants under 8 months. The
J.P. Morgan maintains Hold Rating on Johnson & Johnson, citing growth potential and challenges
J.P. Morgan maintained their Hold Rating on Johnson & Johnson (JNJ) with a price target of $185. Analyst Chris Schott
Wells Fargo maintains Buy rating on Elevance Health (ELV) with unchanged price target.
Elevance Health, Inc. (NYSE: ELV) is listed as one of the 11 Best 52-Week Low Stocks to Buy Right Now.
Diageo plc sells stake in Seychelles Breweries Limited and focuses on high-margin brands
Diageo plc (NYSE:DEO) completed the sale of its 54.4% shareholding in Seychelles Breweries Limited to Phoenix Beverages Limited for approximately
JPMorgan lowered price target on Copart due to market challenges.
Copart, Inc. (NASDAQ:CPRT) reported Q3 2025 results, with revenue at $1.21 billion, a 7.49% increase YoY but missed expectations by
J.P. Morgan maintains Buy rating on Schlumberger Limited with price target of $44
Schlumberger Limited (NYSE:SLB) was named one of the 11 Best 52-Week Low Stocks to Buy Right Now. J.P. Morgan analyst
FDA grants orphan drug designation to Sanofi's Riliprubart for treating antibody-mediated rejection in transplants.
Sanofi (NASDAQ: SNY) received FDA orphan drug designation for Riliprubart to treat antibody-mediated rejection in organ transplants. The designation benefits
Wells Fargo lowers Lowe's price target to $260, maintains buy rating
Lowe’s Companies, Inc. (NYSE:LOW) had its price target reduced by Wells Fargo analyst Zachary Fadem from $300 to $260, maintaining
Accenture (ACN) partners with Palantir (PLTR) to offer AI solutions to US government agencies.
Accenture plc (NYSE:ACN) has partnered with Palantir Technologies Inc. (NASDAQ:PLTR) to provide AI solutions to US federal government agencies. Accenture
Deutsche Bank emphasizes PepsiCo needs investor confidence to address declining snack consumption trends
PepsiCo, Inc. (NASDAQ:PEP) is highlighted as one of the 10 Best Dip Stocks to Buy According to Billionaires. Deutsche Bank
Chevron competing for oil and gas exploration rights in Libya
Chevron Corporation (NYSE:CVX) is competing in Libya’s first oil and gas exploration tender, aiming to restore and boost the country’s
Procter & Gamble plans to cut 7,000 jobs in response to uncertain spending environment
The Procter & Gamble Company (NYSE:PG) is expected to cut 7,000 jobs over the next two years in response to
Amgen's Bemarituzumab shows positive results in phase 3 trial for stomach cancer.
Amgen Inc. (NASDAQ: AMGN) announced positive results for a phase 3 study of Bemarituzumab for certain stomach cancers, meeting its
Wells Fargo stays bullish on Thermo Fisher Scientific, noting positive earnings and growth prospects
Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the 11 Best 52-Week Low Stocks to Buy Right Now, with Wells